Looking deeper into the findings of DARE-19: Failure or an open door to future success?

Pharmacol Res · 2021 · PMC8416358 · PMID 34487851

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

did not reach statistical significancep = 0.14not close (p > 0.1)

547 individuals (87.5%) treated with dapagliflozin and 532 (85.1%) who received placebo experienced clinical status improvement; however, the difference did not reach statistical significance (win ratio 1.09, 95% CI 0.97–1.22; p = 0.14).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.